Ting Liu (Ting Niu)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Randomized Controlled Trial

Histone Deacetylase

Acute Lymphoblastic Leukemia

Top Venues

American journal of hematology

Annals of hematology

Journal of clinical medicine

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Feng, Hongmei Luo, Jingcao Huang, Yue Zhang, Jingjing Wen, Linfeng Li, Ziyue Mi, Qianwen Gao, Siyao He, Xiang Liu, Xinyu Zhai, Xin Wang, Li Zhang, Ting Liu, Yuhuan Zheng
Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib. Cell death & disease 15 (8) (2024)
Yu Feng, Hongmei Luo, Jingcao Huang, Yue Zhang, Jingjing Wen, Linfeng Li, Ziyue Mi, Qianwen Gao, Siyao He, Xiang Liu, Xinyu Zhai, Xin Wang, Li Zhang, Ting Liu, Yuhuan Zheng
Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib. Cell death & disease 15 (8) (2024)
Yu Feng, Hongmei Luo, Jingcao Huang, Yue Zhang, Jingjing Wen, Linfeng Li, Ziyue Mi, Qianwen Gao, Siyao He, Xiang Liu, Xinyu Zhai, Xin Wang, Li Zhang, Ting Liu, Yuhuan Zheng
Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib. Cell death & disease 15 (8) (2024)
Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology (2023)
Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology 98 (4) (2023)
Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology 98 (4) (2023)
Li-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, Ming-Zhi Zhang, Zhi-Ming Li, Chun-Yan Ji, Wei Xu, Ting Liu, Bing Xu, Xin Wang, Su-Jun Gao, Hui-Lai Zhang, Han Yan, Yan Li, Ying Cheng, Hai-Yan Yang, Jun-Ning Cao, Zunmin Zhu, Jian-Da Hu, Wei Zhang, Hong-Mei Jing, Kai-Yang Ding, Xiang-Yang Zhang, Renbin Zhao, Bin Zhang, Ya-Min Tian, Yong-Ping Song, Yu-Qin Song, Jun Zhu
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study. Blood advances (2023)
Yuling Wu, Yue Wang, Jie Ji, Pu Kuang, Xinchuan Chen, Zhigang Liu, Jian Li, Tian Dong, Xuelian Li, Qiang Chen, Ting Liu
A pilot study of cord blood-derived natural killer cells as maintenance therapy after autologous hematopoietic stem cell transplantation. Annals of hematology (2023)
Lijuan Deng, Zhi-Ming Li, Huilai Zhang, Haiwen Huang, Jian-da Hu, Lihong Liu, Ting Liu, Jie Jin, Zunmin Zhu, Wenyu Li, Zhenqian Huang, Wenrong Huang, Ke-Shu Zhou, Haiyan Yang, Mingzhi Zhang, Kaiyang Ding, Hui Zhou, Han Yan, Yuerong Shuang, Junning Cao, Sujun Gao, Dengju Li, Zimin Sun, Qingyuan Zhang, Shuhua Yi, Chun-Yan Ji, Liansheng Zhang, Cheng Hou, Yue Du, Weige Wang, Renbin Zhao, Yuqin Song, Jun Zhu
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label study. American journal of hematology (2023)
Jianying Zhou, Hang Zhang, Yao Qin, Ting Liu
Severe Microcytic Anemia Caused by Complex Hereditary Spherocytosis and X-Linked Sideroblastic Anemia with Mutations in SPTB and ALAS2 Genes. Journal of clinical medicine 12 (5) (2023)
Jianying Zhou, Hang Zhang, Yao Qin, Ting Liu
Severe Microcytic Anemia Caused by Complex Hereditary Spherocytosis and X-Linked Sideroblastic Anemia with Mutations in SPTB and ALAS2 Genes. Journal of clinical medicine 12 (5) (2023)
Jianying Zhou, Hang Zhang, Yao Qin, Ting Liu
Severe Microcytic Anemia Caused by Complex Hereditary Spherocytosis and X-Linked Sideroblastic Anemia with Mutations in SPTB and ALAS2 Genes. Journal of clinical medicine 12 (5) (2023)
Wenwen Wei, Haiyan Ma, Dong Yang, Bin Sun, Jie Tang, Yongjie Zhu, Xinchuan Chen, Xiaoou Huang, Jiazhuo Liu, Zhengfei Hu, Ting Liu, Liqun Zou, Xudong Zhao
SECTM1-based CAR-T cells enriched with CD7low/negative subsets exhibit efficacy in CD7-positive malignancies. Blood advances (2023)
Qi Zhang, He Li, Xuelan Chen, Fan Gu, Lanxin Zhang, Lu Zhang, Tong Chen, Qiang Chen, Wentong Meng, Yu Wu, Hong Chang, Ting Liu, Chong Chen, Hongbing Ma, Yu Liu
Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemia. Blood (2023)
Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology 98 (4) (2023)
Qiang Zeng, Hang Zhang, Pu Kuang, Jian Li, Xinchuan Chen, Tian Dong, Qiuhui Wu, Chuanli Zhang, Chunping Chen, Ting Niu, Ting Liu, Zhigang Liu, Jie Ji
The MAGIC algorithm probability (MAP)-guided preemptive therapy of acute graft versus host disease with methylprednisolone: A randomized controlled trial. American journal of hematology (2023)
Jie Ji, Zhigang Liu, Pu Kuang, Tian Dong, Xinchuan Chen, Jian Li, Chuanli Zhang, Jiazhuo Liu, Li Zhang, Kai Shen, Ting Liu
A new conditioning regimen with chidamide, cladribine, gemcitabine and busulfan significantly improve the outcome of high-risk or relapsed/refractory non-Hodgkin's lymphomas. International journal of cancer 149 (12) (2021)
Haichen Wei, Pu Kuang, Ting Liu
Comparative study on allogeneic with autologous hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in the era of TKIs: a systematic review and meta-analysis. Annals of hematology 99 (11) (2020)
Qiuyang Li, Dewan Zhao, Qiang Chen, Maowen Luo, Jingcao Huang, Cao Yang, Fangfang Wang, Wenxian Li, Ting Liu
Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells. Stem cell research & therapy 10 (1) (2019)
Dewan Zhao, Lingjia Liu, Qiang Chen, Fangfang Wang, Qiuyang Li, Qiang Zeng, Jingcao Huang, Maowen Luo, Wenxian Li, Yuhuan Zheng, Ting Liu
Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34+ cells. Stem cell research & therapy 9 (1) (2018)
Kai Shen, Bing Xiang, Ting Liu
Sweet syndrome secondary to myelodysplastic syndrome mimicking necrotizing fasciitis. Annals of hematology 96 (8) (2017)